About Px HealthCare
Px HealthCare has developed a digital health platform. It combines patient experience with advanced data analytics to improve clinical outcomes in oncology. It was founded in 2012 and is based in London, United Kingdom.
Expert Collections containing Px HealthCare
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Px HealthCare is included in 2 Expert Collections, including Digital Health.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Latest Px HealthCare News
Aug 9, 2021
Key Questions Answered in the Report How has COVID-19 impacted the adoption of urology care devices and platforms applications? What are the key regulations governing the urology care devices and platforms market in key regions? What are the technological developments projected to have the maximum influence on the global urology care devices and platforms market? Who are the leading players holding significant dominance in the global urology care devices and platforms market currently? What are the drivers and restraints for the global urology care devices and platforms market? Which region has the highest growth rate in the urology care devices and platform market? Who are the key end-users of the global urology care devices and platform market? Which are the emerging companies in the global urology care devices and platforms market? Global Urology Care Devices and Platforms Market Drivers The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions. The high susceptibility of diabetic patients to urinary tract infections (UTI) is a major factor for growing urological disorder cases. Thus, with the rise in diabetic patients across the world, UTIs are becoming widespread. There has been a shift in preference by urologists toward single use endoscopes as compared to reusables. This is due to the risk of contamination associated with reusable endoscopes. Additionally, the usage of minimally invasive procedures as treatment for lower urinary tract symptoms (LUTS) has drastically increased since 2013. Lastly, there have also been several key mergers and acquisitions in the field of urology that have driven the global urology care devices and platforms market. This assists the companies in gaining access to newer technologies and strengthening their product offering. Global Urology Care Devices and Platforms Market Challenges The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns. While single use instruments such as endoscopes have benefits that outweigh those of reusable devices, a major limitation encountered with single use instruments is their high upfront cost which puts pressure on the global urology care devices and platforms market. This causes an increase in hospital expenditure which subsequently leads to higher treatment costs. As a result, healthcare becomes both less affordable and accessible. Data breaches are a huge source of concern for healthcare organizations as such incidents can cause legal issues and increase the risk of the practice being shut down. Such cases negatively influence the global urology care devices and platforms market and thus, pose a hindrance to the growth of the market. Global Urology Care Devices and Platforms Market Opportunities The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices. Under the realm of telemedicine, telesurgery is one of the most challenging yet promising areas. Technological advancement and the development of high-speed internet with a wide bandwidth have positively influenced the field of telesurgery and telesurgical monitoring. While telesurgery holds potential in the field of global urology care devices and platforms market, it is advancement in telecommunication technologies that will allow telesurgery's applications in the field of education as well as assistance in urological procedures. With more companies venturing into developing products with novel technologies, there is increased competition among the players in the global urology care devices and platforms market. While the major players in the global urology care devices and platforms market hold a larger market share, newer start-ups are focusing on entering the market by launching products that integrate concepts like artificial intelligence AI and machine learning (ML) into their devices. This gives them an edge over the already existing products. Market Dynamics
Px HealthCare Frequently Asked Questions (FAQ)
When was Px HealthCare founded?
Px HealthCare was founded in 2012.
Where is Px HealthCare's headquarters?
Px HealthCare's headquarters is located at London Bioscience Innovation Centre, London.
What is Px HealthCare's latest funding round?
Px HealthCare's latest funding round is Incubator/Accelerator - II.
How much did Px HealthCare raise?
Px HealthCare raised a total of $340K.
Who are the investors of Px HealthCare?
Investors of Px HealthCare include Startup Creasphere, Nesta, Scottish Funding Council, NHS Innovation Accelerator, Horizon 2020 and 4 more.
Who are Px HealthCare's competitors?
Competitors of Px HealthCare include TytoCare, Syapse, Huma, MDClone, Vinehealth and 7 more.
Compare Px HealthCare to Competitors
CaringBridge is a nonprofit organization focused on providing social networking services in the healthcare domain. The company offers free, personal, and protected websites where individuals can share health updates and receive support from their community during any health journey. Primarily, CaringBridge serves individuals facing health conditions and their support networks. It is based in Eagan, Minnesota.
Mika Health accompanies patients through therapy with a specially developed support program. The company supports cancer patients coping with mental and medical challenges. It was founded in 2017 and is based in Berlin, Germany
Cancer.Net is a company focused on providing oncologist-approved cancer information, operating in the healthcare and information services sector. The company offers comprehensive information for people with cancer, their families, and caregivers, including types of cancer, navigating cancer care, coping with cancer, and survivorship. This information primarily serves individuals living with cancer and those who care for and care about them. It is based in Alexandria, Virginia.
BrightInsight develops a platform for biopharma and medtech-regulated digital health products. The company provides digital health solutions for cardiovascular diseases, diabetes, immunology, oncology, and more. It was formerly known as Flex Digital Health. The company was founded in 2017 and is based in San Jose, California.
MedeAnalytics focuses on healthcare data analytics. The company offers solutions to transform complex healthcare data into actionable insights, with a focus on improving value-based care, population health, financial metrics, and patient outcomes. Their main services include providing analytics for revenue cycle management, value-based care, provider network management, and comprehensive dashboards for government Medicare and Medicaid programs. It was founded in 1994 and is based in Richardson, Texas.
Biofourmis discovers, develops, and delivers clinically-validated, software-based therapeutics. The company produces Biovital, a personalized, artificial intelligence (AI) powered health analytics platform to predict clinical exacerbation. It was founded in 2015 and is based in Boston, Massachusetts.